Ryotaro Asano

511 total citations
38 papers, 262 citations indexed

About

Ryotaro Asano is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Ryotaro Asano has authored 38 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 19 papers in Cardiology and Cardiovascular Medicine and 5 papers in Surgery. Recurrent topics in Ryotaro Asano's work include Pulmonary Hypertension Research and Treatments (22 papers), Cardiovascular Function and Risk Factors (9 papers) and Heart Failure Treatment and Management (5 papers). Ryotaro Asano is often cited by papers focused on Pulmonary Hypertension Research and Treatments (22 papers), Cardiovascular Function and Risk Factors (9 papers) and Heart Failure Treatment and Management (5 papers). Ryotaro Asano collaborates with scholars based in Japan, Australia and New Zealand. Ryotaro Asano's co-authors include Takeshi Ogo, Jin Ueda, Akihiro Tsuji, Satoshi Yasuda, Yoshiaki Morita, Tetsuya Fukuda, Shigefumi Fukui, Yoshihiro Sanda, Yoshikazu Nakaoka and Tomohiko Ishibashi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and PLoS ONE.

In The Last Decade

Ryotaro Asano

30 papers receiving 257 citations

Peers

Ryotaro Asano
Ryotaro Asano
Citations per year, relative to Ryotaro Asano Ryotaro Asano (= 1×) peers Fumiaki Kato

Countries citing papers authored by Ryotaro Asano

Since Specialization
Citations

This map shows the geographic impact of Ryotaro Asano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryotaro Asano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryotaro Asano more than expected).

Fields of papers citing papers by Ryotaro Asano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryotaro Asano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryotaro Asano. The network helps show where Ryotaro Asano may publish in the future.

Co-authorship network of co-authors of Ryotaro Asano

This figure shows the co-authorship network connecting the top 25 collaborators of Ryotaro Asano. A scholar is included among the top collaborators of Ryotaro Asano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryotaro Asano. Ryotaro Asano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Aoki, Tatsuo, Hiroyuki Endo, Takatoyo Kiko, et al.. (2025). Clinical impact of mean pulmonary arterial pressure after balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension. Open Heart. 12(2). e003532–e003532. 1 indexed citations
4.
Asano, Ryotaro, Makoto Okazawa, Tomohiko Ishibashi, et al.. (2025). A Novel Missense Variant of <i>ZC3H12A</i> in Pulmonary Arterial Hypertension. Circulation Reports. 7(3). 207–211.
6.
Kiko, Takatoyo, Ryotaro Asano, Yusuke Yoshikawa, et al.. (2025). Survival trends in patients with chronic thromboembolic pulmonary hypertension: an observational study. European Respiratory Journal. 66(1). 2402268–2402268. 1 indexed citations
7.
Tsuji, Akihiro, Hiroyuki Endo, Takatoyo Kiko, et al.. (2024). Effect of direct oral anticoagulant therapy on pulmonary artery clot dissolution in intermediate high-risk pulmonary thromboembolism. Thrombosis Journal. 22(1). 60–60.
8.
Hirakawa, Kyoko, Ryotaro Asano, Jin Ueda, et al.. (2024). Calcium channel blockers in patients with pulmonary arterial hypertension receiving PAH-specific treatment. International Journal of Cardiology. 406. 132043–132043. 1 indexed citations
9.
Ishibashi, Tomohiko, Tadakatsu Inagaki, Makoto Okazawa, et al.. (2024). IL-6/gp130 signaling in CD4 + T cells drives the pathogenesis of pulmonary hypertension. Proceedings of the National Academy of Sciences. 121(16). e2315123121–e2315123121. 7 indexed citations
10.
Kiko, Takatoyo, Ryotaro Asano, Hiroyuki Endo, et al.. (2024). Balloon pulmonary angioplasty for chronic thromboembolic pulmonary disease without pulmonary hypertension. Pulmonary Circulation. 14(3). e12409–e12409.
11.
Arita, Yoh, Ryotaro Asano, Jin Ueda, et al.. (2024). Perioperative Management of Takayasu Arteritis for Cardiac Surgery ― Review and Single-Center Experience ―. Circulation Journal. 89(12). 1849–1856.
12.
Kiko, Takatoyo, Ryotaro Asano, Tomohiko Ishibashi, et al.. (2024). Prevalence and Clinical Characteristics of Heterozygous RNF213 p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension. Journal of the American Heart Association. 13(15). e035009–e035009. 4 indexed citations
13.
Amano, Masashi, Shoko Nakagawa, Ryotaro Asano, et al.. (2024). Accuracy of Shunt Volume Measured by Three-Dimensional Echocardiography and Cardiac Magnetic Resonance in Patients With an Atrial Septal Defect and a Dilated Right Ventricle. Journal of the American Society of Echocardiography. 37(8). 797–805. 1 indexed citations
14.
Asano, Ryotaro, et al.. (2023). Recurrent pulmonary hypertension after balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension. The Journal of Heart and Lung Transplantation. 43(5). 737–744. 4 indexed citations
15.
Asano, Ryotaro, Tatsuo Aoki, Jin Ueda, et al.. (2022). Prognostic impact of follow-up pulmonary vascular resistance in pulmonary arterial hypertension. Open Heart. 9(1). e002054–e002054. 7 indexed citations
16.
Masaki, Takeshi, Makoto Okazawa, Ryotaro Asano, et al.. (2021). Aryl hydrocarbon receptor is essential for the pathogenesis of pulmonary arterial hypertension. Proceedings of the National Academy of Sciences. 118(11). 31 indexed citations
17.
Asano, Ryotaro, Takeshi Ogo, Yoshiaki Morita, et al.. (2021). Prognostic value of right ventricular native T1 mapping in pulmonary arterial hypertension. PLoS ONE. 16(11). e0260456–e0260456. 6 indexed citations
18.
Nakamura, Kazufumi, Keiko Ohta‐Ogo, Takehiro Tanaka, et al.. (2021). Pathological and clinical effects of interleukin-6 on human myocarditis. Journal of Cardiology. 78(2). 157–165. 11 indexed citations
19.
Asano, Ryotaro, Takeshi Ogo, Keiko Ohta‐Ogo, et al.. (2018). Prolonged QRS duration as a predictor of right ventricular dysfunction after balloon pulmonary angioplasty. International Journal of Cardiology. 280. 176–181. 20 indexed citations
20.
Ueda, Jin, Akihiro Tsuji, Takeshi Ogo, et al.. (2018). Beneficial Effect of Endovascular Treatment on Villalta Score in Japanese Patients With Chronic Iliofemoral Venous Thrombosis and Post-Thrombotic Syndrome. Circulation Journal. 82(10). 2640–2646. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026